Men with NAFLD were more obese and more centrally obese, had higher concentrations of ALT, LDLC, TAG, glucose, insulin, hs-CRP, and FFAs, and more often had type 2 diabetes than men without NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.